PCNA - A cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions

Guido Broich, Anna Maria Lavezzi, Bruna Biondo, Lorenzo D. Pignataro

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Laryngeal squamous cell carcinoma constitutes the most frequent carcinoma found in the head and neck region. A precise prediction for recurrence potential cannot be done on site, treatment and histologic grading. Since Proliferating Cell Nuclear Antigen (PCNA) and DNA-cytometry have shown a good correlation between premalignant lesions and their progressive potential towards full-fledged carcinoma in the larynx as described in part I of this work, we have analyzed the PCNA index and DNA cytometry in specimen taken from vocal chord carcinomas with a 5-year follow-up, in order to assess its relationship with the presence or absence of tumour progression. 42 cases with (21) and without (21) recurrence have been examined. The DNA-index ranged from 1.01 to 1.43 (mean 1.10) in the group without and from 1.02 to 1.59 (mean 1.38) in the group with recurrent carcinoma (p = 0.002). The PCNA-index ranged from 0.00% to 18.90% (mean 6.97%) in the non-recurrent group and from 0.00 to 3g.50% (mean 16.35%) in the patients with recurrence (p = 0.001). Both indices also correlated in a highly significant way. From these data emerges a highly significant correlation between the cytometric indices of cell proliferation and PCNA immunostaining. Furthermore the high correlation between PCNA and DNA-index is of special interest for single case assessment. High DNA aberration and PCNA-index in vocal chord carcinoma may indicate a higher cellular aggressiveness of the tumour, resulting in a greater overall risk of metastases and local recurrences. Our results support the thesis that the indices of cellular proliferation within some cancers can define subsets of patients of high risk and help in isolating a population in which a more aggressive clinical protocol may be proposed.

Original languageEnglish
Pages (from-to)175-178
Number of pages4
JournalIn Vivo
Volume10
Issue number2
Publication statusPublished - 1996

Fingerprint

Vocal Cords
Proliferating Cell Nuclear Antigen
Cell proliferation
Cell Proliferation
Recurrence
Carcinoma
DNA
Neoplasms
Tumors
Clinical Protocols
Larynx
Set theory
Aberrations
Squamous Cell Carcinoma
Neck
Head
Neoplasm Metastasis
Population

Keywords

  • DNA-cytometry
  • Immunohistochemistry
  • PCNA
  • Recurrence in carcinoma
  • Tumour progression
  • Vocal chord carcinoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

PCNA - A cell proliferation marker in vocal cord cancer. Part II : Recurrence in malignant laryngeal lesions. / Broich, Guido; Lavezzi, Anna Maria; Biondo, Bruna; Pignataro, Lorenzo D.

In: In Vivo, Vol. 10, No. 2, 1996, p. 175-178.

Research output: Contribution to journalArticle

Broich, Guido ; Lavezzi, Anna Maria ; Biondo, Bruna ; Pignataro, Lorenzo D. / PCNA - A cell proliferation marker in vocal cord cancer. Part II : Recurrence in malignant laryngeal lesions. In: In Vivo. 1996 ; Vol. 10, No. 2. pp. 175-178.
@article{b6a30e0ea4324af08b56b3503d897b54,
title = "PCNA - A cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions",
abstract = "Laryngeal squamous cell carcinoma constitutes the most frequent carcinoma found in the head and neck region. A precise prediction for recurrence potential cannot be done on site, treatment and histologic grading. Since Proliferating Cell Nuclear Antigen (PCNA) and DNA-cytometry have shown a good correlation between premalignant lesions and their progressive potential towards full-fledged carcinoma in the larynx as described in part I of this work, we have analyzed the PCNA index and DNA cytometry in specimen taken from vocal chord carcinomas with a 5-year follow-up, in order to assess its relationship with the presence or absence of tumour progression. 42 cases with (21) and without (21) recurrence have been examined. The DNA-index ranged from 1.01 to 1.43 (mean 1.10) in the group without and from 1.02 to 1.59 (mean 1.38) in the group with recurrent carcinoma (p = 0.002). The PCNA-index ranged from 0.00{\%} to 18.90{\%} (mean 6.97{\%}) in the non-recurrent group and from 0.00 to 3g.50{\%} (mean 16.35{\%}) in the patients with recurrence (p = 0.001). Both indices also correlated in a highly significant way. From these data emerges a highly significant correlation between the cytometric indices of cell proliferation and PCNA immunostaining. Furthermore the high correlation between PCNA and DNA-index is of special interest for single case assessment. High DNA aberration and PCNA-index in vocal chord carcinoma may indicate a higher cellular aggressiveness of the tumour, resulting in a greater overall risk of metastases and local recurrences. Our results support the thesis that the indices of cellular proliferation within some cancers can define subsets of patients of high risk and help in isolating a population in which a more aggressive clinical protocol may be proposed.",
keywords = "DNA-cytometry, Immunohistochemistry, PCNA, Recurrence in carcinoma, Tumour progression, Vocal chord carcinoma",
author = "Guido Broich and Lavezzi, {Anna Maria} and Bruna Biondo and Pignataro, {Lorenzo D.}",
year = "1996",
language = "English",
volume = "10",
pages = "175--178",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - PCNA - A cell proliferation marker in vocal cord cancer. Part II

T2 - Recurrence in malignant laryngeal lesions

AU - Broich, Guido

AU - Lavezzi, Anna Maria

AU - Biondo, Bruna

AU - Pignataro, Lorenzo D.

PY - 1996

Y1 - 1996

N2 - Laryngeal squamous cell carcinoma constitutes the most frequent carcinoma found in the head and neck region. A precise prediction for recurrence potential cannot be done on site, treatment and histologic grading. Since Proliferating Cell Nuclear Antigen (PCNA) and DNA-cytometry have shown a good correlation between premalignant lesions and their progressive potential towards full-fledged carcinoma in the larynx as described in part I of this work, we have analyzed the PCNA index and DNA cytometry in specimen taken from vocal chord carcinomas with a 5-year follow-up, in order to assess its relationship with the presence or absence of tumour progression. 42 cases with (21) and without (21) recurrence have been examined. The DNA-index ranged from 1.01 to 1.43 (mean 1.10) in the group without and from 1.02 to 1.59 (mean 1.38) in the group with recurrent carcinoma (p = 0.002). The PCNA-index ranged from 0.00% to 18.90% (mean 6.97%) in the non-recurrent group and from 0.00 to 3g.50% (mean 16.35%) in the patients with recurrence (p = 0.001). Both indices also correlated in a highly significant way. From these data emerges a highly significant correlation between the cytometric indices of cell proliferation and PCNA immunostaining. Furthermore the high correlation between PCNA and DNA-index is of special interest for single case assessment. High DNA aberration and PCNA-index in vocal chord carcinoma may indicate a higher cellular aggressiveness of the tumour, resulting in a greater overall risk of metastases and local recurrences. Our results support the thesis that the indices of cellular proliferation within some cancers can define subsets of patients of high risk and help in isolating a population in which a more aggressive clinical protocol may be proposed.

AB - Laryngeal squamous cell carcinoma constitutes the most frequent carcinoma found in the head and neck region. A precise prediction for recurrence potential cannot be done on site, treatment and histologic grading. Since Proliferating Cell Nuclear Antigen (PCNA) and DNA-cytometry have shown a good correlation between premalignant lesions and their progressive potential towards full-fledged carcinoma in the larynx as described in part I of this work, we have analyzed the PCNA index and DNA cytometry in specimen taken from vocal chord carcinomas with a 5-year follow-up, in order to assess its relationship with the presence or absence of tumour progression. 42 cases with (21) and without (21) recurrence have been examined. The DNA-index ranged from 1.01 to 1.43 (mean 1.10) in the group without and from 1.02 to 1.59 (mean 1.38) in the group with recurrent carcinoma (p = 0.002). The PCNA-index ranged from 0.00% to 18.90% (mean 6.97%) in the non-recurrent group and from 0.00 to 3g.50% (mean 16.35%) in the patients with recurrence (p = 0.001). Both indices also correlated in a highly significant way. From these data emerges a highly significant correlation between the cytometric indices of cell proliferation and PCNA immunostaining. Furthermore the high correlation between PCNA and DNA-index is of special interest for single case assessment. High DNA aberration and PCNA-index in vocal chord carcinoma may indicate a higher cellular aggressiveness of the tumour, resulting in a greater overall risk of metastases and local recurrences. Our results support the thesis that the indices of cellular proliferation within some cancers can define subsets of patients of high risk and help in isolating a population in which a more aggressive clinical protocol may be proposed.

KW - DNA-cytometry

KW - Immunohistochemistry

KW - PCNA

KW - Recurrence in carcinoma

KW - Tumour progression

KW - Vocal chord carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030058314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030058314&partnerID=8YFLogxK

M3 - Article

C2 - 8744797

AN - SCOPUS:0030058314

VL - 10

SP - 175

EP - 178

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 2

ER -